By 
The CBD industry has developed at an incredible pace over the last decade. What was once considered a niche market has become a well-established industry, with millions of people across the world now familiar with hemp-derived CBD products. Walk into health food stores, pharmacies or specialist retailers in many countries and you’ll often find CBD products sitting alongside countless other wellness products.
When it comes to pets, however, the picture is far more complicated.
Anyone researching CBD for Pets will quickly discover that different countries take very different approaches to regulation. In some parts of the world, particularly across North America, dedicated pet CBD products have become a significant commercial market, with specialist manufacturers producing oils, treats, capsules and supplements specifically for dogs, cats and other companion animals. By contrast, the UK operates under a much stricter regulatory framework, meaning there are currently no CBD veterinary medicines authorised specifically for general sale for pets. Instead, a veterinary surgeon may prescribe a legally obtained human CBD product under the veterinary prescribing cascade where appropriate.
Understanding these differences helps explain why UK pet owners often encounter conflicting information online. Many articles are written from an American perspective, where the marketplace looks very different, while UK guidance follows its own regulatory pathway.
The Growth Of The American Pet CBD Market
Over recent years, the United States has seen remarkable growth in hemp-derived CBD products designed specifically for companion animals.
Large manufacturers now produce extensive product ranges aimed at dogs, cats and even horses. Pet stores, online retailers and specialist websites all offer a wide variety of CBD products, and the industry has grown into a substantial commercial sector. North America remains the world’s largest market for pet CBD products.
This rapid expansion has been driven by several factors.
Growing public awareness.
Increased investment from manufacturers.
Expanding consumer demand.
Greater availability of hemp-derived products.
As a result, many of the articles, videos and social media discussions UK owners encounter originate from the United States rather than Britain.
That distinction matters.
Why The UK Is Different
The UK has taken a much more cautious regulatory approach.
Rather than treating CBD products for animals as general consumer products, the Veterinary Medicines Directorate (VMD) considers products containing CBD for use in animals to be veterinary medicines. As such, they require a veterinary marketing authorisation before they can be legally sold or supplied for animal use. At present, there are no CBD veterinary medicines with this type of UK authorisation.
This doesn’t mean CBD itself is illegal.
Nor does it mean research has stopped.
Instead, it reflects the UK’s focus on ensuring veterinary medicines are supported by appropriate evidence for safety, quality and efficacy before they are widely authorised.
Why Veterinary Regulation Exists
At first glance, some people view regulation as an obstacle.
In reality, regulation exists for an important reason.
Animals differ enormously in size, metabolism and physiology.
A Chihuahua, a Labrador and a Great Dane cannot automatically be treated in the same way.
The same applies across different species.
Cats.
Dogs.
Rabbits.
Horses.
Each presents different considerations.
Before any veterinary medicine receives full authorisation, regulators expect evidence relating to quality, manufacturing, safety and appropriate use.
This process inevitably takes time.
The Prescribing Cascade
Although there are currently no authorised veterinary CBD medicines generally available in the UK, that does not mean veterinary surgeons have no flexibility.
Where appropriate, vets may prescribe a legally obtained human CBD product under the veterinary prescribing cascade after assessing an individual animal. The cascade is designed to allow vets to use their professional judgement where no suitable authorised veterinary medicine exists for a particular case.
This is an important distinction.
It demonstrates that UK regulation isn’t simply about prohibition.
It’s about ensuring decisions are made under veterinary supervision rather than through unrestricted retail sales.
Why American Articles Can Cause Confusion
Many UK owners naturally search Google for information.
Unfortunately, search results often include American websites.
These articles are frequently well written.
They may contain useful background information.
However, they are usually written for readers living under a completely different regulatory system.
As a result, advice that appears perfectly normal in the United States may not reflect the current legal position in the United Kingdom.
This is one reason responsible UK businesses should always explain current UK guidance rather than simply copying overseas content.
The UK CBD Industry Has Matured
Although the veterinary position remains cautious, the wider UK CBD industry has changed dramatically.
Manufacturing standards have improved.
Independent laboratory testing has become increasingly common.
Consumers ask more informed questions.
Companies have become far more transparent.
Compared with ten years ago, today’s industry is considerably more professional.
These improvements are important because strong manufacturing standards create a better foundation for future regulatory progress.
Why More Research Matters
One of the biggest reasons regulation develops slowly is evidence.
Veterinary medicines require robust scientific data.
Researchers continue to investigate cannabinoids across a variety of veterinary settings, adding to the overall understanding of how these compounds interact with different animal species. Interest from universities and researchers has continued to grow over recent years.
As more high-quality research becomes available, regulators are better placed to evaluate future applications.
Scientific evidence, rather than public opinion, ultimately shapes regulatory decisions.
Could Things Change In The Future?
No one can predict exactly how regulation will develop.
However, history shows that healthcare regulation is constantly evolving.
New medicines are authorised.
Guidelines are updated.
Manufacturing standards improve.
Scientific understanding increases.
The CBD industry itself looks very different today than it did a decade ago.
It is therefore entirely reasonable to think that the veterinary landscape may continue evolving as additional evidence becomes available.
That doesn’t mean changes are guaranteed.
Nor does it mean they will happen quickly.
But medical and veterinary regulation has always developed alongside scientific knowledge.
Why Responsible Companies Remain Patient
For businesses working within the CBD industry, patience is essential.
Responsible companies recognise that building trust is more important than making unrealistic promises.
Rather than attempting to work around regulations, reputable businesses generally support better research, improved manufacturing standards and clearer guidance.
Long-term confidence in the industry depends on these foundations.
Companies that genuinely care about the future understand that credibility cannot be rushed.
Learning From International Markets
The American market offers valuable insights.
It demonstrates strong consumer interest.
It shows the commercial potential of pet CBD products.
It has encouraged significant investment into manufacturing and product development.
At the same time, the UK continues following its own regulatory pathway.
Watching how international markets evolve can be useful, but it doesn’t replace the need to understand UK guidance.
Each country ultimately decides its own regulatory framework.
What This Means For UK Pet Owners
For owners researching CBD today, the most sensible approach is to rely on UK-specific information.
Read guidance produced for UK consumers.
Understand the current regulatory position.
Speak with your veterinary surgeon if you are considering CBD for an individual animal.
Avoid assuming that advice written for another country automatically applies here.
Doing so helps avoid much of the confusion that exists online.
Looking Ahead
The pet CBD industry is still relatively young compared with many other areas of veterinary medicine.
Research continues.
Manufacturing standards continue improving.
Public awareness continues growing.
The UK’s regulatory framework remains focused on ensuring veterinary medicines meet appropriate standards before they are widely authorised, while still allowing vets limited flexibility through the prescribing cascade where appropriate.
Although nobody can say exactly what the future will bring, it seems likely that knowledge surrounding cannabinoids and animal health will continue expanding.
If that happens, future regulatory decisions will be based on stronger scientific evidence than ever before.
For now, the most responsible approach is also the simplest: understand the current UK position, seek veterinary advice where appropriate and choose information from businesses that prioritise education, transparency and honesty over speculation.
Whatever changes may come in the years ahead, those principles are unlikely to change.
Comments